Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported Licence

Exploring the bimodal nature of a nickel-based catalytic system for the hydrogenation of alkenes and polycyclic aromatic hydrocarbons

Samuel Redla, Simon Halasa, Uwe Monkowiusbc and Christoph Topf*a
aInstitute of Catalysis (INCA), Johannes Kepler University (JKU), Linz 4040, Austria. E-mail: christoph.topf@jku.at
bLinz School of Education, Johannes Kepler University (JKU), Linz 4040, Austria
cInstitute of Inorganic Chemistry (JKU), Linz 4040, Austria

Received 10th November 2025 , Accepted 8th January 2026

First published on 8th January 2026


Abstract

We communicate the syntheses, characterization, and catalytic application of a series of NHC-tagged nickel(II) half sandwich complexes (NHC = N-heterocyclic carbene). The described piano stool compounds function as precatalysts in the homogeneous hydrogenation of C[double bond, length as m-dash]C bonds whereby the catalytic protocol is simple, robust, and additive-free. Moreover, one can opt between two modes both of which display distinguished catalytic features that can be exploited to achieve chemo- and regioselectivity. Mechanistic insights are provided with emphasis on the elucidation of the actual catalytically active species and, for the first time, we report on the formation of a hydride-bridged, dinuclear Ni cluster which contains a peculiar, six-membered diaza-nickelacycle. This compound resulted from oxidative addition of an NHC-related C–N bond onto a Ni moiety and this process is likely to represent a general deactivation mode for pertinent nickel catalysts.


Introduction

Catalytic hydrogenation is an indispensable tool for the chemical industries as this technology provides atom-efficient access to commodities and intermediates which are used for the manufacture of many important products including pharmaceuticals, dyes, agrochemicals, or aesthetically pleasing scents.1–3 Typically, the addition of gaseous H2 to organic molecules is achieved through the use of platinum group metals (PGMs). However, economic and scarcity issues associated with these noble elements have spurred the development of hydrogenation catalysts based on non-precious metals.4 In this context, nickel is a suitable candidate due to its excellent abundance, low price, and propensity to form redox active hydrides,5 which is also manifest in the occurrence of Ni in native metalloenzymes.6,7

One of the most prominent catalysts is spongy RANEY® Ni (ref. 8) albeit that its use entails meticulous lab-technical precautions9 and the corresponding catalytic transformations often suffer from limited selectivities.10 In order to remedy these issues, more robust and user-friendly composite materials were devised. These are usually prepared through controlled pyrolyses of a molecularly well-defined solution phase precursor that has been immobilized on supports such as carbon11 or silica12–15 prior to heat treatment. Yet, support-free approaches for the preparation of related, solid hydrogenation catalysts also exist.16

Next to working Ni into heterogeneous formulations, making soluble coordination compounds is a further proper means for achieving catalytic hydrogen transfer with this transition metal.17 Early examples date back to the late 1960s when methyl linoleate and methyl oleate were hydrogenated with plain Ni–PPh3 complexes.18 Later, bidentate phosphines were shown to enable the efficient hydrogenation of 1-octene19–21 and the privileged PNP pincer motif gave rise to related catalysts for the hydrogenation of C[double bond, length as m-dash]C bonds, too.22,23 Nickel complexes containing classic N-heterocyclic carbenes24 (NHC) as well as analogous silylenes25,26 and silyl ligands27 complement this list. Moreover, N-donor ligands such as phosphoranimides28 and Schiff bases29 are well-suited for the design of catalysts that facilitate the reduction of olefins with molecular hydrogen. Very interestingly, the activation of H2 is also possible at Ni–M interfaces (M = B, Al, Ga, or In)30–32 and even Mg-based metalloligands cleave the strong H–H (ref. 33) or D–D (ref. 34) bond, respectively. Most importantly, Ni-based coordination compounds that incorporate enantiopure phospholanes35 or chiral-at-P phosphines36 allow for the asymmetric reduction of C[double bond, length as m-dash]C bonds.

With respect to C[triple bond, length as m-dash]C, the selective semihydrogenation of alkynes with several Ni/phosphine combinations37–39 including an Si-based pincer ligand40 has been reported. In addition, a Ni-gallylene motif was exploited to achieve the same catalytic transformation.41

Now, in order to expand upon our research program on hydrogenation catalysts derived from group 6 metal half sandwich complexes,42,43 we embarked on a study towards the development of structurally related organonickel species. For that purpose, compounds of the general formula [Ni(η5-Cp)(NHC)X] (X = Cl, Br) fit well by virtue of their ready accessibility.44–48 We chose NHCs as these compounds have emerged as a highly versatile ligand class in catalysis49 since the isolation of the first stable carbene.50 Furthermore, we wanted to bypass problems associated with the air sensitivity of phosphines which often interferes with the catalytic activity of pertinent complexes.51

Occasional reports on the catalytic capabilities of [Ni(η5-Cp)(NHC)]-based coordination compounds have been published in the context of P4 activation,52 hydroboration,53 and hydrosilylation.54–56 In the context of hydrogenation, olefin-tethered complexes [Ni(η5-Cp)(NHC)X] (X = Cl, Br) were employed as precursors for the preparation of NHC-tagged nanoparticles which function as a catalysts in various hydrogenation reactions.57–59 Yet, to the best of our knowledge, an atom-efficient, homogeneous(-like) method for the reduction of C[double bond, length as m-dash]C bonds relying on Ni-derived piano stool complexes has not been reported so far. Herein, we present a flexible and user-friendly catalytic protocol which deploys gaseous H2 as the principal reductant and that dispenses with the need for any companion reagents such as strong bases or moisture-sensitive hydrides.

Results and discussion

Catalytic pretests and optimization studies

Initially, we probed a series of NHC-tagged piano stool chlorides [Ni] 1–5 for their ability to function as precatalysts in the hydrogenation of alkenes (Table 1). The conversion of cyclooctene 1a into cyclooctane 2a was chosen as a standard of comparison and in order to convert the Cl complexes into the corresponding hydrides, which are supposed to actually promote the hydrogenation process, the benchmark reaction was conducted in the presence of an auxiliary reagent (LiHBEt3). We found that the activity of the complexes strongly depends upon the NHC's wingtip substituents, i.e., the Dipp-bearing (Dipp = 2,6-diisopropylphenyl) complexes ([Ni] 3, [Ni] 4) performed best and enabled complete substrate conversion whereas the Mes-substituted (Mes = 2,4,6-trimethylphenyl) congeners ([Ni] 1, [Ni] 2) seriously lagged behind (entries 1–4). Moreover, the degree of saturation in the imidazole-derived portion of the NHC proved to be relevant: imidazoline-based moieties (SIMes and SIPr) gave rise to more active catalysts compared to their imidazole counterparts (IMes and IPr) which still contain a C[double bond, length as m-dash]C bond in the 4,5-position. The effect became evident when the hydrogenation experiment was run at lower H2 pressure, i.e., 5 vs. 20 bar (entries 8 and 9). The large discrepancy in activity between [Ni] 2 and [Ni] 4 can be attributed to cluster formation that forestalls the hydrogenation process (vide infra). The bis(imino)acenaphthene-derived carbene SBIAN-Mes60,61 motif seems to curb the catalyst deactivation associated with the Mes groups but still this precatalyst could not compete with ones containing the standard Dipp-substituted NHCs (entry 5).
Table 1 Precatalyst testing for the pressure hydrogenation of alkenes

image file: d5cy01341k-u1.tif

Entry [Ni] precursor p H2/bar Conv.a/%
a Determined by means of GC-MS analyses (n-hexadecane served as the internal standard).b The addition of LiHBEt3 prompted the formation of the 17e species [Ni(η5-Cp*)(SIPr)].
1 [Ni] 1 20 15
2 [Ni] 2 20 25
3 [Ni] 3 20 >99
4 [Ni] 4 20 >99
5 [Ni] 5 20 88
6 [Ni] 5-Br 20 61
7b [Ni] 4-Cp* 20 >99
8 [Ni] 3 5 22
9 [Ni] 4 5 34
10 [Ni] 4-H, no LiHBEt3 20 >99


In order to render the transformation 1a2a additive-free, we first synthesized the hydride [Ni] 4-H in a separate step and applied it directly without any companion reagent and, rewardingly, we were able to reproduce the result obtained with the [Ni] 4/LiHBEt3 in situ system (entry 10). Interestingly, treatment of congeneric [Ni] 4-Cp* with LiHBEt3 did not yield a hydride but gave the paramagnetic, 17e species [Ni(η5-Cp*)SIPr] instead. Yet, the latter performed excellent in the model reaction (entry 7) but since paramagnetic species often obstruct mechanistic investigations, especially with regard to NMR spectroscopy, we focused on Cp complexes that were diamagnetic, 18e complexes.

Since isolable [Ni] 4-H is a fairly stable, 18e complex, we reasoned that this is not the true catalyst that brings about the alkene hydrogenation. Thus, in order to generate the notional active species, [Ni] 4-H was first subjected to an H2 atmosphere (45 °C, 20 bar) for 3 h whereupon 1a was added to the reaction solution (Table 2). Strikingly, substrate conversion was complete within only 5 min and without the preactivation step, 1 h was necessary to fully convert cyclooctene (entries 1 and 3). To our delight, once [Ni] 4-H had been activated, the conversion 1a2a took place under very mild reaction conditions (5 bar H2, RT) and even under 1 bar H2 albeit longer reaction times were necessary to achieve meaningful conversions (entries 8 and 10). Importantly, both preactivation and cyclooctene hydrogenation were, not at all, hampered by the presence of Hg which points towards an authentic, homogeneous hydrogenation pathway (entry 2).

Table 2 Control experiments under preactivation conditions

image file: d5cy01341k-u2.tif

Entry Deviation from the standard procedure Conv.a/%
a Determined by means of GC-MS analyses (n-hexadecane served as the internal standard).b 150 equiv. of liquid mercury vs. [Ni] 4-H were added.c 2 equiv. of LiHBEt3 vs. [Ni] 4 were added.
1 None >99
2b Hg drop test >99
3 No preactivation step, 1 h in step 2) >99
4 No preactivation step, 1 h in step 2), 1-octene instead of cyclooctene in step 2) <10
5 1-Octene served as the substrate in step 2) >99
6 [Ni] 2-H (SIMes) instead of [Ni] 4-H (SIPr) 26
7c [Ni 4]/LiHBEt3 instead of [Ni] 4-H >99
8 5 bar H2, RT, and 1 h were applied in step 2) >99
9 As in entry 8, but 5 bar H2 in step 1) 16
10 1 bar H2, RT, and 1 h were applied in step 2) 40


Furthermore, we established that catalyst formation is strongly affected by the nature of the alkene: on using non-activated [Ni] 4-H and 1-octene, the entire hydrogenation process was sluggish and only a minor fraction of the olefin was converted. However, when a preactivated sample of [Ni] 4-H was applied, hydrogenation of the same terminal alkene was again possible within a very short period of time (entries 4 and 5). It turned out that if the terminal olefin is present from the outset, a considerably stable bis(alkene) complex is formed that obstructs the generation of the active species (vide infra). On the other hand, the alkene does not impede the catalytic transformation if [Ni] 4-H is activated prior to olefin addition.

Mechanistic studies

Hydrogenation of [Ni] 4-H in THF-d8 gave a complex 1H NMR spectrum with various hydride signals in the high-field range, i.e., from −4 to −26 ppm (Fig. 1A) including the one of remaining [Ni] 4-H at −23.6 ppm. The COSY plot shows three mutually coupled hydrides that are associated with the active species as these signals vanish upon addition of cyclooctene; however new hydridic signals emerged (SI). In the reaction mixture, we also detected cyclopentane which was presumably formed through expulsion of CpH from the Ni precatalyst followed by hydrogenation of the C[double bond, length as m-dash]C bonds thus leaving behind a [Ni(0)NHC] unit. Notably, a similar route for the formation of a NHC-tagged Ni(0) species was previously reported in the context of C–H activation.62 The invoked Ni carbene is then likely to aggregate into a polyhydride cluster [NixHY(SIPR)z] that displays hydrogenation capabilities in its own right. Since a catalytically active, phosphine-tagged polynuclear Ni complex has already been described in the literature, the existence of NHC analogs is reasonable.63 Very recently, in situ formed, soluble Ni-nanoclusters were identified as the active species in the unusual geminal dihydroboration of alkynes.64 Just like in our case, the higher nuclearity of the catalyst enables unprecedented reactivity, demonstrating the potential that lies beyond the traditional binary classification into homogeneous and heterogeneous catalysis.
image file: d5cy01341k-f1.tif
Fig. 1 (A, left) 1H COSY NMR spectrum of a hydrogenated sample of [Ni] 4-H in THF-d8 highlighting the hydridic region. (A, right) Excerpt of the 1H NMR spectrum of hydrogenated [Ni] 4-H before and after the addition of cyclooctene showing the emergence of new hydride species; *hydride signal of unreacted precursor [Ni] 4-H. (B) Hydrogenation of [Ni] 4-H in toluene furnished stable [Ni(0)(SIPr)(η6-toluene)] that afforded a fairly unreactive bis(alkene) complex upon reaction with a terminal, aliphatic olefin. (C) Hydrogenation of kindred [Ni] 2-H produced the unusual cluster compound [Ni2]H-SIMes by way of oxidative addition. (D) Molecular structure of [Ni2]H-SIMes as determined by SC-XRD analysis; all hydrogen atoms, except for the bridging hydride, were omitted for brevity.

As free [Ni(0)NHC] complexes are not stable and tend to form higher aggregates65 we performed the [Ni] 4-H hydrogenation in toluene to intercept the pertinent carbene complex as stable [Ni(0)(SIPr)(η6-toluene)] (Fig. 1B).66 If not prohibited by steric hindrance, aliphatic alkenes may substitute for the arene to yield 16e bis(alkene) complexes.67,68 The ability of NHC-tagged motifs to form such intermediates thus provides a rationale for the fact that some olefins are hydrogenated at slower rates compared to standard cyclooctene especially when the alkene is already present next to unactivated [Ni] 4-H (Table 2, entry 4).

Note that the reduction of [Ni] 4-H with gaseous H2 is a robust alternative to [Ni(COD)2]-based approaches for the preparation of [Ni(arene)(NHC)] complexes that serve as convenient Ni carbene synthons.

Next, the SIMes congener [Ni] 2-H was hydrogenated and, to our surprise, we found that its imidazoline moiety did not maintain its integrity but underwent ring expansion to afford a hitherto unknown nickelacycle that dominates the structure of the formed cluster [Ni2]H-SIMes (Fig. 1C). The constitution of the H-bridged, dinuclear complex was confirmed by SC-XRD analysis (Fig. 1D) together with 1H NMR spectroscopy. In light of the fact that imidazole-based NHCs are generally seen as inert spectator ligands, the oxidative addition of the pertinent C–N bond onto [Ni(0)(SIMes)] is a remarkable result. Interestingly, the cluster formation is independent of the solvent and any attempts at isolating [Ni(0)(SIMes)(η6-toluene)], in order to intercept the elusive [Ni(0)(SIMes)] fragment, failed.

Note that our experimental findings are reminiscent of a recent report dealing with the synthesis and characterization of a cyclic Fe carbyne complex.69 In that case, a C–S bond of a 4-thiazoline core underwent oxidative addition to furnish the corresponding six-membered metallacycle.

Importantly, [Ni2]H-SIMes is not a self-contained catalyst but still, its formation is not a dead end: keeping the cluster under an atmosphere of H2 at elevated temperature, catalytic activity is regained (SI). In that sense, the cluster generation is just a temporary deactivation process.

Next, we looked into the interaction between different alkene substrates and [Ni(0)(SIPr)(η6-toluene)] which can be viewed as an arene-stabilized version of the fugacious (but very crucial) [Ni(0)(SIPr)] unit. Treatment of the Ni(arene) complex with excess cyclooctene Li (4 equiv.) in THF-d8 caused full displacement of toluene upon which the proton resonances of the associated Li moiety appeared as a set of three broad signals shifted upfield compared to free cyclooctene (Fig. 2A) thus indicating a chemical exchange process. Since broad coalescence between coordinated and free Li is observed, the magnitude of the exchange rate k is similar to that of the complexation-induced shift (CIS) Δν.70,71 As an aside, the latter is exceptionally large for complexes of the type [Ni(0)(alkene)2NHC] by virtue of strong backdonation from the Ni center into the antibonding alkene's π* orbital.24,67,72 In case of Ni-bound Li, the protons directly attached to the C-sp2 atoms experience the largest broadening while that of the other H atoms pertaining to cyclooctene decreases as the distance to the C[double bond, length as m-dash]C bond increases. Concurrently, all H signals associated with the SIPr ligand appear as sharp lines since they all fall into the fast exchange regime (k > Δν).


image file: d5cy01341k-f2.tif
Fig. 2 (A, top) Displacement of η6-coordinated toluene through reaction with cyclooctene (Li); the line broadening in the 1H spectrum is due to exchange between free and bound Li. (A, bottom) reaction between 1-octene (Lt) and [Ni(0)(SIPr)(η6-toluene)] yields relatively stable [Ni(0)(Lt)2(SIPr)]; in this case, dynamic behavior is not observed on the NMR time scale. (B) Conversion-time diagram showing the influence of substrate and solvent on the catalytic hydrogenation's rate. The indices i and t stand for ‘internal’ and ‘terminal’, respectively. Conditions: 0.5 mmol substrate, 1 mol% [Ni] 4-H, 1.0 ml solvent, 20 bar H2, 45 °C. [Ni(0)] refers to [Ni(0)(SIPr)(η6-toluene)].

Concerning the number of cyclooctenes that coordinate to the [Ni(SIPr)] fragment, we refer to previously published calculations that were performed on [Ni(COD)(SIPr)] (COD = 1,5-cyclooctadiene).73 These showed that COD solely bonds in the η2 mode and the formation of the bis-COD congener [Ni(η2-COD)2(SIPr)] is strongly hampered due to steric constraints; for the same reason, the isomer [Ni(η22-COD)(SIPr)] cannot form. Hence, given the great similarity of COD and Li, we used this computational study to argue that the equilibrium [Ni(Li)(SIPr)] + Li ⇄ [Ni(Li)2(SIPr)] takes place whereat the left side of the reaction equation is favored.

By contrast, reaction of [Ni(SIPr)(η6-toluene)] with 1-octene Lt (4 equiv.) produced well-defined signal sets for the free and coordinated olefins of the 1H NMR spectrum (Fig. 2A). This indicates that any exchange processes between free and coordinated alkene are slow compared to when cyclooctene is present (vide supra). Furthermore, the analogous reaction [Ni(Lt)(SIPr)] + Lt ⇄ [Ni(Lt)2(SIPr)] is now clearly biased towards the right side (quantitative formation of [Ni(Lt)2(SIPr)] according to 1H NMR) because Lt can avoid steric clash as terminal olefins are more flexible than internal ones. Hence, the formation of the congested, but rather stable, 16e species [Ni(Lt)2(SIPr)] becomes feasible. The latter also reinforces the fact that 1-octene's hydrogenation rate is drastically reduced compared to cyclooctene (Table 2, entry 4) since, obviously, the bis(alkene) complex is more stable presumably due to stereoelectronic effects. Yet, it has to be mentioned here, that Ni-promoted activation of H2 is also possible on crowded 16e species as shown by Moret and coworkers. In their study, an olefin-substituted diphosphine complex was shown to heterolytically cleave H2 by way of cooperation between the alkene tether and the Ni center;39 similar activation pathways could also exist for related NHC complexes.

The kinetic profiles for the hydrogenation of cyclooctene and 1-octene reflect their different coordination behavior (Fig. 2B). On using precatalyst [Ni] 4-H in 1,4-dioxane, cyclooctene was fully converted within 45 min (black trace) whereas the reduction of 1-octene was sluggish, i.e., only 60% conversion were achieved after 6 h (green trace). This observation is in agreement with the presence of the more reactive, 14e species [Ni(Li)(SIPr)] and less reactive, sterically congested 16e intermediate [Ni(Lt)2(SIPr)]. Importantly, the kinetic curve for the catalytic transformation conducted with [Ni(SIPr)(η6-toluene)] in the same solvent (blue trace) parallels that of the experiment that was run with [Ni] 4-H. This indicates that both routes proceed through a common intermediate that actually sustains the catalytic cycle, i.e., [Ni(SIPr)]. This assertion is supported by the fact that cyclooctene reduction is severely hampered if performed in toluene (red trace). In this case, any free [Ni(SIPr)] is immediately captured as the stable, 18e complex [Ni(SIPr)(η6-toluene)] which is not a catalyst on its own. Note that this finding also underlines that benzene-derived solvents are not the ideal choice for hydrogenations promoted by Ni–NHCs since they readily form stable intermediates with the solvent that impede the catalytic hydrogenation process as a whole.24

Substrate scope and limitations

Building upon the initial catalytic experiments we established a protocol for olefin hydrogenation that relies on the substrate-coordinating mononuclear [Ni(NHC)] motif (mode I, Scheme 1, left column) and one that rests on the formation of rather ill-defined polyhydride clusters [NixHY(SIPR)z] (mode II, Scheme 1, right column). Generally, mode I is apt for the reduction of internal alkenes whereas terminal ones are better accommodated by mode II. Notably, when we first applied mode I to cis-stilbene 1s and the conjugated diene 1v we observed substantial byproduct formation due to partial or full hydrogenation of the Ph rings. However, on using mode II, the formation of unwanted side products was effectively curbed. Note that bicyclic norbornene 1u is a substrate on which mode I performed only poorly. Although being an internal alkene, 1u presumably forms a fairly stable complex by virtue of its compact shape.
image file: d5cy01341k-s1.tif
Scheme 1 Percentage values refer to isolated yields if not stated otherwise; 1GC-MS yield (n-hexadecane served as the internal standard); 2NMR yield (1,3,5-trimethoxybenzene served as the internal standard); a16 h reaction time; b3 h reaction time during 2); cmixture of products due to arene-hydrogenation; d2 mol% [Ni] 4-H; e2 mol% [Ni] 4-H, THF, and 3 h reaction time during 2).

In the case of α,β-unsaturated ketones, we found that the conjugated C[double bond, length as m-dash]C bond in benzylidene acetone 1e was preferably reduced thus leaving the carbonyl group mostly intact. Yet, in trans-chalcone 1f where the Me group is substituted for a Ph substituent the C[double bond, length as m-dash]O group was hydrogenated to produce the corresponding secondary alcohol. Concerning the conjugated esters 1g–i, the catalytic conversion was selective in that the C[double bond, length as m-dash]C bond next to the ester group was reduced while the CO2R motif itself remained untouched. Diethyl fumarate 1j was unreactive owing to the formation of stable [Ni(fumarate)2NHC].74 Preactivation of the catalyst did not lead to any significant improvement in this case. Rewardingly, mode I copes with steric bulk such that the trisubstituted cinnamate derivative 1i was neatly converted into the wanted product. Interestingly, the same system was unable to fully convert simple cinnamaldehyde 1d whereas challenging citral 1l and geraniol 1m, both of which contain two trisubstituted olefin moieties, were regioselectively reduced at the conjugated site and not at the periphery. However, tetrasubstituted alkene motifs were not converted and β-ionone 1n gave, accordingly, the alcohol that stems from reduction of the C[double bond, length as m-dash]O group and the disubstituted C[double bond, length as m-dash]C bond.

Mode II excels in the reduction of terminal alkenes and, gratifyingly, the catalytic transformation is not obstructed by deleterious oxidative addition that might occur in aryl halides 1x, 1y, and 1af. Interestingly, under the conditions of mode I, α-methylstyrene 1ae underwent exhaustive hydrogenation to produce isopropyl cyclohexane as the major product (>90%) whereas the cluster-supported approach was more selective and gave cumene almost exclusively. We attribute the exhaustive hydrogenation to a mechanistic pathway initiated by arene-coordination to [Ni(0)SIPr] and the alkene-activating effect (SI).75 Hydrogenation of limonene 1ah yielded a well-balanced diastereomeric mixture of cis- and trans-menthane and even a highly functionalized molecule such as quinine 1aj was cleanly converted.

The hydrogenation of fused arenes (mode I) typically required forced reaction conditions (increased loading of [Ni] 4-H, higher temperature, and/or higher H2 pressure) in order to achieve decent substrate conversions (Scheme 2). However, unsubstituted naphthalene and anthracene were partially reduced under comparably low precatalyst loading (2 mol% [Ni] 4-H) and H2 pressure (20 bar). Under these conditions, anthracene was reduced mainly to tetrahydroanthracene. Applying the standard conditions gave 4gAC as the main product instead. Substituted naphthalenes required 5 mol% of the precatalyst and with respect to regioselectivity, we found that the unsubstituted moiety had been preferentially hydrogenated with selectivities ranging from 4.5[thin space (1/6-em)]:[thin space (1/6-em)]1 for 4d to 12[thin space (1/6-em)]:[thin space (1/6-em)]1 for 4e. Notably, phenanthrene and pyrene called for the harshest conditions (60 °C, 40 bar H2) so as to achieve satisfying results. Hydrogenation of quinoline (3a) failed, most likely due to the stability of the dimer [(η2-quinoline)Ni(SIPr)]2.65


image file: d5cy01341k-s2.tif
Scheme 2 Substrate scope for the hydrogenation of polycyclic aromatic hydrocarbons. 5 mol% of [Ni] 4-H, 40 bar H2 and 45 °C were applied as standard conditions with the following adjustments: 2 mol% of [Ni] 4-H and 20 bar H2 for 3b, 10 mol% and 60 °C for 3i, 60 °C for 3j. With the exception of 4b, products were isolated as a mixture and each yield was determined by means of 1H NMR spectroscopy (1,3,5-trimethoxybenzene served as the internal standard). Capital letters indicate hydrogenated carbocycles.

Miscellaneous and outlook

To expand upon the application range of our [Ni(NHC)]-based system, we tested preactivated [Ni] 4-H for its ability to promote chain walking isomerization since we frequently observed minor quantities of olefin isomers in the reaction mixture. Indeed, eugenol 1ai was neatly converted into trans-isoeugenol 1ai′ at mild temperature (60 °C, Scheme 3A). This shows that the pertinent Ni–NHC can also be applied as a self-contained alkene isomerization catalyst.
image file: d5cy01341k-s3.tif
Scheme 3 Further applications and tunability of the catalytic system. (A) Isomerization of eugenol into trans-isoeugenol. (B) In situ-generated [Ni(SIPr)2] functions as a more active catalyst for the hydrogenation of 1-octene compared to [Ni(0)(SIPr)(η6-toluene)]. (C) Ni-catalyzed hydrogenation of prochiral substrates into racemic products; a16 h reaction time. (D) Deliberate catalyst poisoning with benzaldehyde to circumvent the reduction of the ketone motif in trans-chalcone.

Next, we wanted to know whether the one-coordinate [Ni(NHC)] catalyst ceases to work in the presence of excess carbene ligand. For that purpose, [Ni(SIPr)(η6-toluene)] was first combined with SIPr to afford homoleptic [Ni(SIPr)2] which was then applied to the hydrogenation of cyclooctene. Surprisingly, the bis(NHC) complex was still catalytically competent despite increased steric bulk and reduced vacancies at the Ni center. Then, [Ni(SIPr)2] was used as a presumptive catalyst in the hydrogenation of 1-octene. The intention here was to forestall the detrimental formation of a bis(alkene) complex which was shown to impede the catalytic process (vide supra). To our delight, also this olefin was smoothly converted into the wanted alkane (Scheme 3B). Thus, using [Ni(SIPr)2] offers an alternative way of reducing terminal alkenes without prior activation of [Ni] 4-H (mode II).

During the elaboration of the substrate scope, mode I enabled the hydrogenation of several prochiral substrates such as citral 1l, α-pinene 1o, and ethyl β-methyl cinnamate 1i (Scheme 1). Adding ketones and ketimines makes an array of substrates, the asymmetric hydrogenation of which accesses interesting chiral building blocks (alcohols, amines, and saturated esters). Interestingly, we found that C[double bond, length as m-dash]O and C[double bond, length as m-dash]N bonds have also succumbed to catalytic hydrogenation effected by [Ni] 4-H (Scheme 3C). Since NHC ligands can be made chiral these important preliminary results open up new vistas for the development of base metal catalysts that enable enantioselective hydrogenation reactions.

Lastly, we wanted to ameliorate the selectivity towards the C[double bond, length as m-dash]C bond in the conjugate reduction of enones (Scheme 3D). We hypothesized that an aldehyde additive could prevent the ketone motif from binding to the Ni core thus leaving it behind unaltered after the hydrogenation experiment. This approach was guided by the idea that the Ni(0)-catalyzed Tishchenko reaction, initiated by [Ni(aldehyde)2(NHC)], might outcompete the formation of an oxanickelacycle via reaction between Ni(0)NHC and the ketone.76,77 The latter is a plausible starting point for the hydrogenation of ketones with Ni(0)NHC as a catalyst. Indeed, we found that benzaldehyde effectively suppresses the reduction of the C[double bond, length as m-dash]O group in trans-chalcone to exclusively afford the tagged ketone 2f′. Incidentally, benzaldehyde ended up as benzyl alcohol and benzyl benzoate as the homocoupling product.76

Conclusions

We established a general, [Ni(SIPr)]-based catalytic protocol for the homogeneous hydrogenation of olefins. An analogous, SIMes-derived catalyst furnishes a peculiar, six-membered nickelacycle that represents a temporarily deactivated state which can be reactivated under an atmosphere of H2. The SIPr-based system is more flexible and can be used in two ways. The first mode relies on a molecularly well-defined, substrate-coordinating [Ni(SIPr)] unit and is apt for the reduction of internal C[double bond, length as m-dash]C bonds. The second one rests on the generation of (polynuclear) Ni hydrides that are more suitable for the hydrogenation of terminal alkenes. Both modes do not require any additives (bases, auxiliary hydrides) which renders the catalytic methods atom-efficient and economical.

The fact that the described Ni catalyst also brings about the reduction of ketones and ketimines blazes the trail for the development of new asymmetric hydrogenation catalysts. This and the potential of the Ni–NHC complexes to function as catalysts beyond hydrogenation applications are currently examined in our research laboratories.

Experimental

Catalytic hydrogenation without preactivation (mode I)

In a glovebox, glass vials (4 mL) equipped with a stirring bar were charged with the substrate (0.50 mmol). The respective amount of precatalyst ([Ni] 4-H, 1 mol% or as stated) was added as a stock solution. Then, solvent was added until the total volume amounted to 1.0 mL. The vials were closed with a screw cap equipped with a PTFE-coated rubber septum, placed inside an Al inlet, and taken out from the glovebox. Each septum was pierced with a cannula and the vials together with the inlet were placed inside the autoclave which was then flushed with Ar for 15 s, tightly sealed, purged with H2 (3 × 10 bar, 2 × 20 bar) and pressurized with 20 bar H2. The thus-prepared steel vessel was then placed into a preheated (45 °C) water bath and the reaction mixture stirred for 3 h. After cooling to room temperature, the overpressure was released and the autoclave was disassembled. The reaction mixtures were analyzed via GC-MS. If conversions or yields were determined via GC-MS analysis, stock solution of n-hexadecane was added after the reaction. Standard conditions: 1 mol% [Ni] 4-H, 1,4-dioxane, 45 °C, 20 bar H2, 3 h. Deviating reaction conditions and workup methods are described in the supporting information for each substrate.

Catalytic hydrogenation with preactivation (mode II)

The same procedure as was followed for mode I was applied but no substrate was added at first. After preactivation for 3 h at 45 °C under 20 bar H2, the autoclave was disassembled and the cannulas were quickly removed. Liquid substrates were added through a Hamilton syringe whereas solid substrates were weighed into a separate glass vial in the glovebox. The vials were tightly sealed and then removed from the box. The preactivated catalyst solution was transferred to the substrate-containing vial with a syringe. The septa were then pierced again with cannulas and the autoclave (preheated bottom part at 45 °C) assembled and charged with H2 according to the standard procedure. The remaining steps were performed as described for mode I. Standard conditions: 1 mol% [Ni] 4-H, 1,4-dioxane, 45 °C, 20 bar H2, and 30 min. Deviating reaction conditions and workup methods are described in the SI for each substrate.

Catalytic hydrogenation of polycyclic aromatic hydrocarbons

The same procedure as delineated for mode I was used. Exact reaction conditions and purification methods are described in the supporting information for each substrate. In most cases, hydrogenation gave at least two products which were not separated during the course of the purification step. Instead, the respective yields were determined by way of 1H NMR spectroscopy using 1,3,5-trimethoxybenzene as internal standard.

Author contributions

S. R.: writing – original draft, methodology, investigation, conceptualization. S. H.: investigation. U. M.: crystal structures. C. T.: writing – review & editing, writing – original draft, validation, supervision, conceptualization.

Conflicts of interest

The authors declare no competing financial interest.

Data availability

All data supporting this article have been included as part of the supplementary information (SI).

Supplementary information: experimental and procedural details, mechanistic studies, NMR spectra (1H, 13C), single crystal X-ray diffraction analyses (tabular information, pictorial representations), HRMS. See DOI: https://doi.org/10.1039/d5cy01341k.

CCDC 2493261–2493267 and 2493739 contain the supplementary crystallographic data for this paper.78a–h

Acknowledgements

We gratefully thank Univ.-Prof. Dr. Marko Hapke from the INCA (Linz) for fruitful discussions and the generous support as well as assoc. Univ.-Prof. Dr. Markus Himmelsbach and Laura Zellner MSc from the Institute of Analytical and General Chemistry at the JKU for performing the HRMS measurements.

References

  1. H.-J. Arpe, Industrial Organic Chemistry, Wiley-VCH, Weinheim, 5th edn, 2010 Search PubMed.
  2. J. Hagen, Industrial Catalysis: A Practical Approach, Wiley-VCH, Weinheim, 3rd edn, 2015 Search PubMed.
  3. A. Behr, T. Seidensticker and D. Vogt, Applied Homogeneous Catalysis: A Tool for Sustainable Chemistry, Wiley-VCH, Weinheim, 2nd edn, 2025 Search PubMed.
  4. R. M. Bullock, J. G. Chen, L. Gagliardi, P. J. Chirik, O. K. Farha, C. H. Hendon, C. W. Jones, J. A. Keith, J. Klosin, S. D. Minteer, R. H. Morris, A. T. Radosevich, T. B. Rauchfuss, N. A. Strotman, A. Vojvodic, T. R. Ward, J. Y. Yang and Y. Surendranath, Science, 2020, 369, eabc3183 CrossRef CAS PubMed.
  5. N. A. Eberhardt and H. Guan, Chem. Rev., 2016, 116, 8373–8426 CrossRef CAS PubMed.
  6. W. Weigand and P. Schollhammer, Bioinspired Catalysis: Metal-Sulfur Complexes, Wiley-VCH, Weinheim, 2015 Search PubMed.
  7. N. Lalaoui, I. Suarez-Antuna, S. Arjunan, M. Curtil, I. Polydoros-Chrysovalantis, F. Molton, P. Y. Chavant, C. Philouze, A. Milet, P. Maldavi and C. Duboc, ACS Org. Inorg. Au, 2025, 5, 230–237 CrossRef CAS PubMed.
  8. M. Raney, US Pat., US1563587, 1925 Search PubMed.
  9. J. Sales, F. Mushtaq, M. D. Christou and R. Nomen, Study of Major Accidents Involving Chemical Reactive Substances: Analysis and Lessons Learned, Process. Saf. Environ. Prot., 2007, 85, 117–124 CrossRef CAS.
  10. Y. Tamaru, Modern Organonickel Chemistry, Wiley-VCH, Weinheim, 2005 Search PubMed.
  11. S. Pisiewicz, D. Formenti, A.-E. Surkus, M.-M. Pohl, J. Radnik, K. Junge, C. Topf, S. Bachmann, M. Scalone and M. Beller, ChemCatChem, 2016, 8, 129–134 CrossRef CAS.
  12. P. Ryabchuk, G. Agostini, M.-M. Pohl, H. Lund, A. Agapova, H. Junge, K. Junge and M. Beller, Sci. Adv., 2018, 4, eaat0761 CrossRef PubMed.
  13. J. Michalke, K. Faust, T. Bögl, S. Bartling, N. Rockstroh and C. Topf, Int. J. Mol. Sci., 2022, 23, 8742 CrossRef CAS PubMed.
  14. Y. Hu, M. Liu, S. Bartling, H. Lund, H. Atia, P. J. Dyson, M. Beller and R. V. Jagadeesh, Sci. Adv., 2023, 9, eadj8225 CrossRef CAS PubMed.
  15. J. Michalke, D. Böhm, F. Schmiedbauer, J. F. Schwarz, L. S. Vogl, S. Bartling, N. Rockstroh and C. Topf, Tetrahedron Green Chem, 2024, 3, 100036 CrossRef.
  16. X. Cui, Y. Hangkong, K. Junge, C. Topf, M. Beller and F. Shi, Green Chem., 2017, 19, 305–310 RSC.
  17. V. Vermaak, H. C. M. Vosloo and A. J. Swarts, Coord. Chem. Rev., 2024, 507, 215716 CrossRef CAS.
  18. H. Itatani and J. C. Bailar, J. Am. Chem. Soc., 1967, 89, 1600–1602 CrossRef CAS.
  19. I. M. Angulo, A. M. Kluwer and E. Bouwman, Chem. Commun., 1998, 2689–2690 RSC.
  20. I. M. Angulo and E. Bouwman, J. Mol. Catal. A: Chem., 2001, 175, 65–72 CrossRef CAS.
  21. I. M. Angulo, E. Bouwman, R. van Gorkum, S. M. Lok, M. Lutz and A. L. Spek, J. Mol. Catal. A: Chem., 2003, 202, 97–106 CrossRef CAS.
  22. K. V. Vasudevan, B. L. Scott and S. K. Hanson, Eur. J. Inorg. Chem., 2012, 2012, 4898–4906 CrossRef CAS.
  23. Z. Wei, Y. Ren, X. Tian, C. Shen and H. Jiao, J. Catal., 2024, 431, 115372 CrossRef CAS.
  24. J. Wu, J. W. Faller, N. Hazari and T. J. Schmeier, Organometallics, 2012, 31, 806–809 CrossRef CAS.
  25. Y. Wang, A. Kostenko, S. Yao and M. Driess, J. Am. Chem. Soc., 2017, 139, 13499–13506 CrossRef CAS PubMed.
  26. M.-P. Lücke, S. Yao and M. Driess, Chem. Sci., 2021, 12, 2909–2915 RSC.
  27. T. M. Saunders, K. N. Roberston and L. Turculet, ChemCatChem, 2024, 16, e202400654 CrossRef CAS.
  28. J. Camacho-Bunquin, M. J. Ferguson and J. M. Stryker, J. Am. Chem. Soc., 2013, 135, 5537–5540 CrossRef CAS PubMed.
  29. N. G. Léonard and P. J. Chirik, ACS Catal., 2017, 8, 342–348 CrossRef.
  30. W. H. Harman and J. C. Peters, J. Am. Chem. Soc., 2012, 134, 5080–5082 CrossRef CAS PubMed.
  31. T.-P. Lin and J. C. Peters, J. Am. Chem. Soc., 2014, 136, 13672–13683 CrossRef CAS PubMed.
  32. R. C. Cammarota and C. C. Lu, J. Am. Chem. Soc., 2015, 137, 12486–12489 CrossRef CAS PubMed.
  33. Y. Cai, S. Jiang, T. Rajeshkumar, L. Maron and X. Xu, J. Am. Chem. Soc., 2022, 144, 16647–16655 CrossRef CAS PubMed.
  34. Y. Cai, M. Wang, Y. Yang and X. Xu, Inorg. Chem., 2025, 64, 14598–14605 CrossRef CAS PubMed.
  35. M. Shevlin, M. R. Friedfeld, H. Sheng, N. A. Pierson, J. M. Hoyt, L.-C. Campeau and P. J. Chirik, J. Am. Chem. Soc., 2016, 138, 3562–3569 CrossRef CAS PubMed.
  36. B. Li, Z. Wang, Y. Luo, H. Wei, J. Chen, D. Liu and W. Zhang, Nat. Commun., 2024, 15, 5482 CrossRef CAS PubMed.
  37. K. Murugesan, C. B. Bheeter, P. R. Linnebank, A. Spannenberg, J. N. Reek, R. V. Jagadeesh and M. Beller, ChemSusChem, 2019, 12, 3363–3369 CrossRef CAS PubMed.
  38. N. O. Thiel, B. Kaewmee, T. Tran Ngoc and J. F. Teichert, Chem. – Eur. J., 2020, 26, 1597–1603 CrossRef CAS PubMed.
  39. M. L. G. Sansores-Paredes, M. Lutz and M.-E. Moret, Nat. Chem., 2024, 16, 417–425 CrossRef CAS PubMed.
  40. D. J. Hale, M. J. Ferguson and L. Turculet, ACS Catal., 2021, 12, 146–155 CrossRef.
  41. T. L. Kalkuhl, I. Fernández and T. J. Hadlington, Chem, 2025, 11, 102349 CAS.
  42. T. Vielhaber, C. Heizinger and C. Topf, J. Catal., 2021, 404, 451–461 CrossRef CAS.
  43. T. Vielhaber, K. Faust, T. Bögl, W. Schöfberger and C. Topf, J. Catal., 2022, 416, 352–363 CrossRef CAS.
  44. Ł. Banach, P. A. Guńka, J. Zachara and W. Buchowicz, Coord. Chem. Rev., 2019, 389, 19–58 CrossRef.
  45. C. D. Abernethy, A. H. Cowley and R. A. Jones, J. Organomet. Chem., 2000, 596, 3–5 CrossRef CAS.
  46. R. A. Kelly, N. M. Scott, S. Díez-González, E. D. Stevens and S. P. Nolan, Organometallics, 2005, 24, 3442–3447 CrossRef CAS.
  47. B. Landers and O. Navarro, Inorg. Chim. Acta, 2012, 380, 350–353 CrossRef CAS.
  48. V. Ritleng, C. Barth, E. Brenner, S. Milosevic and M. J. Chetcuti, Organometallics, 2008, 27, 4223–4228 CrossRef CAS.
  49. E. Peris, Chem. Rev., 2018, 118, 9988–10031 CrossRef CAS PubMed.
  50. A.-J. Arduengo III, R. L. Harlow and M. Kline, J. Am. Chem. Soc., 1991, 113, 361–363 CrossRef.
  51. P. W. N. M. van Leeuwen and J. C. Chadwick, Homogeneous Catalysts: Activity-Stability-Deactivation, Wiley, VCH Weinheim, 2011 Search PubMed.
  52. S. Pelties, D. Herrmann, B. de Bruin, F. Hartl and R. Wolf, Chem. Commun., 2014, 50, 7014–7016 RSC.
  53. F. Ulm, Y. Cornaton, J.-P. Djukic, M. J. Chetcuti and V. Ritleng, Chem. – Eur. J., 2020, 26, 8916–8925 CrossRef CAS PubMed.
  54. L. P. Bheeter, M. Henrion, L. Brelot, C. Darcel, M. J. Chetcuti, J.-B. Sortais and V. Ritleng, Adv. Synth. Catal., 2012, 354, 2619–2624 CrossRef CAS.
  55. L. P. Bheeter, M. Henrion, M. J. Chetcuti, C. Darcel, V. Ritleng and J.-B. Sortais, Catal. Sci. Technol., 2013, 3, 3111–3116 RSC.
  56. F. Ulm, S. Shahane, L. Truong‐Phuoc, T. Romero, V. Papaefthimiou, M. Chessé, M. J. Chetcuti, C. Pham‐Huu, C. Michon and V. Ritleng, Eur. J. Inorg. Chem., 2021, 30, 3074–3082 CrossRef.
  57. M. G. Avello, S. Golling, L. Truong-Phuoc, L. Vidal, T. Romero, V. Papaefthimiou, N. Gruber, M. J. Chetcuti, F. R. Leroux, M. Donnard, V. Ritleng, C. Pham-Huu and C. Michon, Chem. Commun., 2023, 59, 1537–1540 RSC.
  58. M. G. Avello, J. Blas Martínez, T. Romero, V. Papaefthimiou, M. J. Chetcuti, V. Ritleng, C. Pham-Huu, C. Oelschlaeger and C. Michon, ACS Sustainable Chem. Eng., 2024, 12, 10739–10751 CrossRef CAS.
  59. M. G. Avello, G. Singh, L. Truong-Phuoc, L. Vidal, V. Papaefthimiou, M. Chessé, N. Gruber, M. J. Chetcuti, K. Vanka, V. Ritleng, C. Pham-Huu and C. Michon, J. Catal., 2026, 453, 116487 CrossRef CAS.
  60. H. Türkmen, O. Şahin, O. Büyükgüngör and B. Çetinkaya, Eur. J. Inorg. Chem., 2006, 2006, 4915–4921 CrossRef.
  61. S. Redl, D. Timelthaler, P. Sunzenauer, K. Faust and C. Topf, Organometallics, 2023, 42, 1639–1648 CrossRef CAS.
  62. O. V. Khazipov, K. E. Shepelenko, D. V. Pasyukov, V. V. Chesnokov, S. B. Soliev, V. M. Chernyshev and V. P. Ananikov, Org. Chem. Front., 2021, 8, 2515–2524 RSC.
  63. R. Beck, M. Shoshani and S. A. Johnson, Angew. Chem., Int. Ed., 2012, 51, 11753–11756 CrossRef CAS PubMed.
  64. Y. Su, K. Shen, P. Shi, C. Liu, S. Song, H. Yi, A. Lei, Y. Liu, H. Wang, X. Li, Q. Luo, C. Xu and X. Wang, J. Am. Chem. Soc., 2025, 147, 39561–39571 CrossRef CAS PubMed.
  65. B. Sawatlon, T. Wititsuwannakul, Y. Tantirungrotechai and P. Surawatanawong, Dalton Trans., 2014, 43, 18123–18133 RSC.
  66. Y. Hoshimoto, Y. Hayashi, H. Suzuki, M. Ohashi and S. Ogoshi, Organometallics, 2014, 33, 1276–1282 CrossRef CAS.
  67. N. I. Saper, A. Ohgi, D. W. Small, K. Semba, Y. Nakao and J. F. Hartwig, Nat. Chem., 2020, 12, 276–283 CrossRef CAS PubMed.
  68. C. Nie, C. Park, J. Kim and P. J. Chirik, J. Am. Chem. Soc., 2024, 146, 24818–24831 CrossRef CAS PubMed.
  69. J. Rao, S. Dong, C. Yang, Q. Liu, X. Leng, D. Wang, J. Zhu and L. Deng, J. Am. Chem. Soc., 2023, 145, 25766–25775 CrossRef CAS PubMed.
  70. M. P. Williamson, Prog. Nucl. Magn. Reson. Spectrosc., 2013, 73, 1–16 CrossRef CAS PubMed.
  71. I. R. Kleckner and M. P. Foster, Biochim. Biophys. Acta, Proteins Proteomics, 2011, 1814, 942–968 CrossRef CAS PubMed.
  72. M. J. Iglesias, J. F. Blandez, M. R. Fructos, A. Prieto, E. Álvarez, T. R. Belderrain and M. C. Nicasio, Organometallics, 2012, 31, 6312–6316 CrossRef CAS.
  73. Y. Zhou, X. Cui, Y. Yang and Z.-Z. Xie, Organometallics, 2024, 43, 987–997 CrossRef CAS.
  74. C. Berini, O. H. Winkelmann, J. Otten, D. A. Vicic and O. Navarro, Chem. – Eur. J., 2010, 16, 6857–6860 CrossRef CAS PubMed.
  75. J. C. Greenbaum, A. J. King, M. V. Pecoraro, P. Tosatti and K. Puentener, J. Am. Chem. Soc., 2025, 147, 30423–30435 CrossRef CAS PubMed.
  76. Y. Hoshimoto, M. Ohashi and S. Ogoshi, Acc. Chem. Res., 2015, 48, 1746–1755 CrossRef CAS PubMed.
  77. Y. Cai, L. Ruan, A. Rahman and S. Shi, Angew. Chem., Int. Ed., 2021, 60, 5262–5267 CrossRef CAS PubMed.
  78. (a) CCDC 2493261: Experimental Crystal Structure Determination, 2025,  DOI:10.5517/ccdc.csd.cc2ppfsm;; (b) CCDC 2493262: Experimental Crystal Structure Determination, 2025,  DOI:10.5517/ccdc.csd.cc2ppftn; (c) CCDC 2493263: Experimental Crystal Structure Determination, 2025,  DOI:10.5517/ccdc.csd.cc2ppfvp; (d) CCDC 2493264: Experimental Crystal Structure Determination, 2025,  DOI:10.5517/ccdc.csd.cc2ppfwq; (e) CCDC 2493265: Experimental Crystal Structure Determination, 2025,  DOI:10.5517/ccdc.csd.cc2ppfxr; (f) CCDC 2493266: Experimental Crystal Structure Determination, 2025,  DOI:10.5517/ccdc.csd.cc2ppfys; (g) CCDC 2493267: Experimental Crystal Structure Determination, 2025,  DOI:10.5517/ccdc.csd.cc2ppfzt; (h) CCDC 2493739: Experimental Crystal Structure Determination, 2025,  DOI:10.5517/ccdc.csd.cc2ppy6k.

This journal is © The Royal Society of Chemistry 2026
Click here to see how this site uses Cookies. View our privacy policy here.